Cargando…

Cancer and mTOR inhibitors in kidney transplantation recipients

BACKGROUND: Previous studies show that mTOR inhibitors decrease the risk of cancer development after kidney transplantation. However, the effect of cumulative doses of mTOR inhibitors on cancer after kidney transplantation is not well known. METHODS: In the current study, patients were registered in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kao, Chih-Chin, Liu, Jia-Sin, Chang, Yu-Kang, Lin, Ming-Huang, Lin, Yen-Chung, Chen, Hsi-Hsien, Chang, Wei-Chiao, Hsu, Chih-Cheng, Wu, Mai-Szu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2018
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237112/ https://www.ncbi.nlm.nih.gov/pubmed/30473931 http://dx.doi.org/10.7717/peerj.5864

Ejemplares similares

Health policies on dialysis modality selection: a nationwide population cohort study
por: Lin, Yi-Chun, et al.
Publicado: (2017)

Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012
por: Lin, Yen-Chung, et al.
Publicado: (2015)

Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005–2012
por: Liu, Chung-Te, et al.
Publicado: (2017)

Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
por: Lin, Hugo You-Hsien, et al.
Publicado: (2014)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021)

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan
por: Lee, Kwai-Fong, et al.
Publicado: (2016)

AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest
por: Yu, Chih-Chia, et al.
Publicado: (2016)

mTOR Inhibitors Induce Erythropoietin Resistance in Renal Transplant Recipients
por: Jefferies, Reece, et al.
Publicado: (2022)

Clinical Mass Spectrometry Discovered Human IgG Sialylation as a Potential Biosignature for Kidney Function
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Fatal Outcome in a Kidney-Pancreas Transplant Recipient With COVID-19
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
por: Chou, Ming-Huei, et al.
Publicado: (2021)

Medical Aspects of mTOR Inhibition in Kidney Transplantation
por: Cuadrado-Payán, Elena, et al.
Publicado: (2022)

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
por: Campos-Salazar, Antony Brayan, et al.
Publicado: (2018)

Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis
por: Lin, Yi-Chun, et al.
Publicado: (2016)

Disseminated Nocardia paucivorans Infection Resembling Metastatic Disease in a Kidney Transplant Recipient
por: Luu, Tyler, et al.
Publicado: (2022)

Risk of liver injury after α-glucosidase inhibitor therapy in advanced chronic kidney disease patients
por: Kao, Chih-Chin, et al.
Publicado: (2016)

Non-meningeal, non-pulmonary cryptococcosis with limited posterior uveitis in a kidney organ transplant recipient with antibody-mediated rejection: a case report
por: Lu, Yi-An, et al.
Publicado: (2023)

Long-Term Redistribution of Peripheral Lymphocyte Subpopulations after Switching from Calcineurin to mTOR Inhibitors in Kidney Transplant Recipients
por: Llinàs-Mallol, Laura, et al.
Publicado: (2020)

mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction
por: Infante, Barbara, et al.
Publicado: (2021)

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study
por: Vela, Carla, et al.
Publicado: (2022)

Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control
por: Shu, Chin-Chung, et al.
Publicado: (2020)

Different effect of hypercholesterolemia on mortality in hemodialysis patients based on coronary artery disease or myocardial infarction
por: Lin, Yi-Chun, et al.
Publicado: (2016)

Effects of Periodontal Treatment in Patients with Periodontitis and Kidney Failure: A Pilot Study
por: Chung, Wen-Chen, et al.
Publicado: (2022)

V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients
por: Wong, Henry Sung-Ching, et al.
Publicado: (2017)

Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?
por: Geissler, Edward K
Publicado: (2015)

Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway
por: Lin, Yu-Tsai, et al.
Publicado: (2017)

p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
por: Wu, I-Wen, et al.
Publicado: (2011)

Association of UBE3C Variants with Reduced Kidney Function in Patients with Diabetic Kidney Disease
por: Chen, Ying-Chun, et al.
Publicado: (2020)

Evaluation of quantitative changes in regulatory T cells in peripheral blood of kidney transplant recipients with skin cancer after conversion to mTOR inhibitors
por: Cegielska, Agnieszka, et al.
Publicado: (2018)

Intestinal goblet cell carcinoid presenting with recurrent sterile peritonitis in a patient on peritoneal dialysis: a case report
por: Chen, Chih-Wei, et al.
Publicado: (2017)

Hyperleptinemia is associated with the aortic augmentation index in kidney transplant recipients
por: Chen, Yen-Cheng, et al.
Publicado: (2018)

Effect of Dialysis Modalities on All-Cause Mortality and Cardiovascular Mortality in End-Stage Kidney Disease: A Taiwan Renal Registry Data System (TWRDS) 2005–2012 Study
por: Su, Po-Cheng, et al.
Publicado: (2022)

Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth: A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease
por: Friedrich, L., et al.
Publicado: (2012)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Place of mTOR inhibitors in management of BKV infection after kidney transplantation
por: Jouve, Thomas, et al.
Publicado: (2016)

mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis
por: Xie, Xishao, et al.
Publicado: (2015)

Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review
por: Olszewska, Berenika, et al.
Publicado: (2023)

Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan
por: Liu, Hsi-Ling, et al.
Publicado: (2023)

Long-term risk of dementia following acute kidney injury: A population-based study
por: Kao, Chih-Chin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4c47lh6bbdmb7ecp0tejeihjj4